TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.

Ravindra Uppaluri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.